IntrinsicIntrinsic
← Scroll for more →

Financial Statements — ABOS

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Cash & Equivalents53.0859.4451.8053.9946.8336.8130.1635.6333.1867.9646.9366.8994.9277.2578.00130.10157.54111.07108.76122.16
Short-term Investments25.5350.7576.6062.8879.78106.56118.99135.93167.16192.52205.58176.64120.5267.6362.4147.5042.6578.8480.3372.08
Total Current Assets85.13115.51133.09122.25132.15148.40154.95178.31207.63266.92255.83246.62218.60149.54144.03180.33202.56191.05192.10198.66
Property, Plant & Equipment0.070.080.090.100.120.130.140.070.090.110.120.120.120.140.150.170.140.110.050.04
Total Non-current Assets*0.430.490.540.5810.0723.4949.5360.6959.3422.0045.1463.5167.7727.8743.8316.260.7020.6327.9931.67
Total Assets85.57116.01133.63122.83142.22171.90204.48238.99266.98288.91300.97310.13286.37177.41187.86196.59203.26211.68220.09230.33
Accounts Payable6.0613.381.660.550.682.101.065.652.344.213.081.381.362.030.761.642.081.711.221.09
Short-term Debt20.4019.6714.128.773.60------------------------------
Total Current Liabilities45.0946.8529.2330.0121.9624.8619.3227.6119.9115.378.4712.976.108.538.787.816.615.133.94--
Long-term Debt5.8711.9016.9222.4027.0529.8829.5329.4229.6729.3830.2129.90----------------
Total Non-current Liabilities*5.8711.9016.9222.4027.0929.9629.6429.5729.8629.6030.4630.180.000.000.000.000.000.030.06--
Total Liabilities50.9658.7446.1552.4049.0554.8248.9657.1849.7744.9738.9343.156.108.538.787.816.615.164.005.15
Retained Earnings(525.29)(499.92)(467.20)(446.46)(421.32)(394.87)(353.92)(325.13)(287.97)(258.21)(237.67)(222.80)(206.30)(193.34)(181.73)(170.43)(157.56)(146.85)(136.70)(127.57)
Total Stockholder Equity34.6157.2687.4870.4393.17117.08155.52181.82217.20243.95262.03266.97280.27168.87179.09188.78196.65206.52216.09225.18
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Research & Development21.1127.8116.4820.5321.9737.1325.2734.5727.2519.5312.4513.2911.189.138.7110.758.317.325.995.67
Selling, General & Admin4.704.754.674.674.554.635.105.035.024.855.335.194.864.354.423.503.063.093.222.74
Total Operating Expenses25.8132.5621.1525.2026.5141.7530.3739.6032.2724.3817.7718.4916.0413.4813.1414.2511.3710.419.218.41
Operating Income(25.81)(32.56)(21.15)(25.20)(26.51)(41.75)(30.37)(39.60)(32.26)(24.38)(17.77)(18.49)(16.04)(13.48)(13.13)(14.25)(11.37)(10.41)(9.21)(8.41)
Interest Expense--------------------1.00------------------
Net Income(25.37)(32.72)(20.74)(25.14)(26.45)(40.95)(28.80)(37.15)(29.76)(20.54)(14.87)(16.50)(12.96)(11.61)(11.31)(12.87)(10.71)(10.15)(9.13)(8.35)
Basic EPS(0.35)(0.45)(0.33)(0.40)(0.44)(0.68)(0.48)(0.62)(0.50)(0.34)(0.25)(0.28)(0.24)(0.28)(0.28)(0.32)(0.26)(0.25)----
Diluted EPS(0.35)(0.45)(0.33)(0.40)(0.44)(0.68)(0.48)(0.62)(0.50)(0.34)(0.25)(0.28)(0.24)(0.28)(0.28)(0.32)(0.26)(0.25)----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Operating Cash Flow(26.65)(18.07)(24.13)(19.10)(30.49)(31.83)(34.12)(27.21)(24.60)(16.55)(17.86)(8.31)(12.90)(11.67)(10.18)(11.20)(9.18)(6.47)(8.30)(3.64)
Capital Expenditures0.000.000.000.000.000.010.080.000.000.010.010.010.010.000.000.040.080.040.010.03
Free Cash Flow*(26.65)(18.07)(24.13)(19.10)(30.49)(31.84)(34.20)(27.21)(24.60)(16.55)(17.87)(8.33)(12.91)(11.67)(10.18)(11.24)(9.26)(6.50)(8.31)(3.66)
Investing Cash Flow25.2526.00(13.81)26.2540.5138.4828.6929.66(10.13)37.70(9.20)(48.81)(92.00)11.06(41.93)(20.42)55.928.79(5.10)(10.01)
Financing Cash Flow(4.96)(0.28)35.740.000.000.00(0.04)(0.01)(0.04)(0.13)7.1129.13122.76(0.14)--4.18(0.26)(0.01)--0.01
← Scroll for more columns →

* Derived from reported values